Kst Pharmaceuticals Private Limited, a active private limited company, was established on 11 December 2019 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290TG2019PTC137497. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.40 Cr.
Employing 52 professional, Its leadership includes Surapaneni Tarunya (Director), Kalyan Satyamani Vankayalapati (Director). It holds ₹23.84 Cr open charges and ₹25.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at F.No: 106, First Floor, Ganapati Complex D.No: 8-3-678/42,C1 Toc4,Yellareddy Guda, Hyderabad, Telangana, 500045.
U24290TG2019PTC137497
137497
11 December 2019
₹10.00 Cr
₹9.40 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Kst Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surapaneni Tarunya | Director | 11 Dec 2019 | Current |
| Kalyan Satyamani Vankayalapati | Director | 11 Dec 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kst Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 178.26% decrease in profit. The company's net worth observed a substantial decline by a decrease of 26.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Kst Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹238,414,080.00
₹250,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 May 2023 | Hdfc Bank Limited | ₹23.84 Cr | Open |
| 15 Jun 2021 | Canara Bank | ₹25.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Kst Pharmaceuticals has a workforce of 52 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kst Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kst Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kst Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on A charge registered on 15 Jun 2021 via Charge ID 100461287 with Canara Bank was fully satisfied on 22 Nov 2024. was documented.
The activity Kst Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 23.84 Cr with Charge ID 100734531 was registered on 25 May 2023. was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 25.00 Cr with Charge ID 100461287 was registered on 15 Jun 2021. was documented.
Surapaneni Tarunya was appointed as a Director was appointed as a Director on 11 Dec 2019 & has been associated with this company since 6 years 1 month . was recorded as a recent event.
The CIN of Kst Pharmaceuticals Private Limited is U24290TG2019PTC137497.
Kst Pharmaceuticals Private Limited is headquartered at F.No: 106, First Floor, Ganapati Complex D.No: 8-3-678/42,C1 Toc4,Yellareddy Guda, Hyderabad, Telangana, 500045.
Kst Pharmaceuticals Private Limited was incorporated on 11 December 2019.
The current directors of Kst Pharmaceuticals Private Limited are
The primary industry of Kst Pharmaceuticals Private Limited is Manufacturing.
Kst Pharmaceuticals Private Limited is unlisted.
The authorized capital of Kst Pharmaceuticals Private Limited is ₹10.00 Cr, and the paid-up capital is ₹9.40 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX